Literature DB >> 21540042

MicroRNA in lung cancer diagnostics and treatment.

Marcin Skrzypski1, Rafał Dziadziuszko, Jacek Jassem.   

Abstract

MicroRNAs (miRs) are short RNA chains that regulate gene expression by inhibition of mRNA translation. Their expression is often deranged in cancer. Increasing evidence indicates that these molecules play an important role in oncogenesis and cancer progression. This review focuses on the clinical application of miRs in lung cancer, with the emphasis on detection of early lung cancer, prognostication and chemotherapy sensitivity prediction. Methodological aspects of studies on prognostic markers in early NSCLC are outlined in detail. Finally, modulation of miR expression in lung cancer as a therapeutic possibility is discussed. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540042     DOI: 10.1016/j.mrfmmm.2011.04.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  30 in total

1.  MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.

Authors:  Hao Chang; Yue-Hong Liu; Li-Li Wang; Ju Wang; Zhi-Hong Zhao; Jun-Feng Qu; Sheng-Fa Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 2.  The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club.

Authors:  Isabelle Opitz; Thomas A D'Amico; Gaetano Rocco
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

Review 3.  Role of MicroRNAs in lung disease.

Authors:  Martín Angulo; Emilia Lecuona; Jacob Iasha Sznajder
Journal:  Arch Bronconeumol       Date:  2012-05-17       Impact factor: 4.872

4.  Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer.

Authors:  Jun Shen; Feng Jiang
Journal:  Expert Opin Med Diagn       Date:  2012-05

Review 5.  MicroRNA-21 gene and cancer.

Authors:  Yong Huang; You Bing Yang; Xiao Hui Zhang; Xue Li Yu; Zhan Bin Wang; Xiang Chao Cheng
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

6.  MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.

Authors:  Fangchao Gong; Ping Ren; Yan Zhang; Jindong Jiang; Hong Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

7.  Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.

Authors:  Sining Shen; Han Yue; Yin Li; Jianjun Qin; Ke Li; Ying Liu; Jiaxiang Wang
Journal:  Tumour Biol       Date:  2014-01

8.  Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.

Authors:  Prasant Yadav; Masroor Mirza; Kajal Nandi; S K Jain; R C M Kaza; Nita Khurana; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2016-09-30

9.  MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1.

Authors:  Haitao Luo; Caixia Liang
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

10.  miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.

Authors:  Xingyu Lin; Zhiguang Yang; Peng Zhang; Yunpeng Liu; Guoguang Shao
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.